 |
Open for inclusion |
A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemiaCancer type: Leukemia Phase: II Principal Investigator: Büchner Jochen Country: NO Keywords: Norway, Oslo, Pediatric, CTL019 and acute lymphoblastic leukemia Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02435849?term=CCTL019B2202&rank=1 |